On Tuesday, Summit Therapeutics Inc (NASDAQ: SMMT) opened lower -8.62% from the last session, before settling in for the closing price of $18.62. Price fluctuations for SMMT have ranged from $15.55 to $36.91 over the past 52 weeks.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -10.52%. Company’s average yearly earnings per share was noted -325.00% at the time writing. With a float of $102.73 million, this company’s outstanding shares have now reached $744.44 million.
Summit Therapeutics Inc (SMMT) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Summit Therapeutics Inc is 86.17%, while institutional ownership is 14.08%. The most recent insider transaction that took place on Oct 21 ’25, was worth 9,999,983. In this transaction Director of this company bought 533,617 shares at a rate of $18.74, taking the stock ownership to the 32,057,147 shares. Before that another transaction happened on Oct 21 ’25, when Company’s Co-Chief Executive Officer bought 26,680 for $18.74, making the entire transaction worth $499,983. This insider now owns 76,680 shares in total.
Summit Therapeutics Inc (SMMT) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.06 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.06) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -325.00% per share during the next fiscal year.
Summit Therapeutics Inc (NASDAQ: SMMT) Trading Performance Indicators
Check out the current performance indicators for Summit Therapeutics Inc (SMMT). In the past quarter, the stock posted a quick ratio of 3.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.91 in one year’s time.
Technical Analysis of Summit Therapeutics Inc (SMMT)
Compared to the last year’s volume of 3.67 million, its volume of 3.34 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 54.43%.
During the past 100 days, Summit Therapeutics Inc’s (SMMT) raw stochastic average was set at 9.11%, which indicates a significant decrease from 40.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.97 in the past 14 days, which was lower than the 1.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.18, while its 200-day Moving Average is $21.96. Nevertheless, the first resistance level for the watch stands at $18.03 in the near term. At $19.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $19.55. If the price goes on to break the first support level at $16.51, it is likely to go to the next support level at $16.00. Now, if the price goes above the second support level, the third support stands at $14.99.
Summit Therapeutics Inc (NASDAQ: SMMT) Key Stats
There are currently 771,150K shares outstanding in the company with a market cap of 12.64 billion. Presently, the company’s annual sales total 0 K according to its annual income of -221,320 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -231,790 K.
